Sanuwave Health Inc.

SNWV Healthcare Medical Devices

Sanuwave Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.1 million, up 35.0% from fiscal 2024.

Revenue
−3.13%
EPS
−224.2%
Free cash flow
+86.8%
Total debt
−28.4%

Quarter to June 2026, against a year earlier

2.20 0.05 −2.22%
Market cap
$19.4M
P/E
1.3×
Fwd P/E
−211×
Dividend yield
—
F-score
6/9
Altman Z
−2.97
Beneish M
−0.90
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
3 4 3 4 4 3 5 4 5 6
P/E ratio
62.02 62.02 62.02 62.02 62.02 62.02 62.02 62.02 0.00 20.80
P/S ratio
1.42 1.42 1.42 1.42 1.42 1.42 1.42 1.42 3.15 5.80
Altman Z-Score
— — — — — — — — (10.06) (2.97)
P/FCF ratio
117.92 117.92 117.92 117.92 117.92 117.92 117.92 117.92 52.24 34.96
Altman Z″-Score (non-manufacturers)
(391.38) (339.69) (450.52) (158.70) (37.98) (56.29) (53.29) (48.94) (32.94) (19.06)
P/Operating CF
32.38 32.38 32.38 32.38 32.38 32.38 32.38 32.38 138.52 76.99
Beneish M-Score
(14.22) (18.29) (33.36) (2.12) 3.54 (6.45) (0.43) (6.97) (7.78) (0.90)
P/B ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 157.84
EV/Sales
2.17 2.17 2.17 2.17 2.17 2.17 2.17 2.17 3.61 6.03
EV/EBITDA
5.74 5.74 5.74 5.74 5.74 5.74 5.74 5.74 11.20 34.53
EV/FCF
180.56 180.56 180.56 180.56 180.56 180.56 180.56 180.56 59.94 36.33
Current Ratio
0.12 0.11 0.07 0.20 0.22 0.08 0.11 0.15 0.41 1.38
Net Debt/EBITDA
0.03 (0.03) (1.19) 0.11 (0.09) (1.24) (4.35) 2.85 1.44 1.30
Debt/Equity
(0.01) (0.08) (0.35) (0.08) (0.33) (0.32) (0.35) (0.53) (1.61) 13.56
ROE
100.69% 65.96% 92.18% 82.06% 260.18% 103.50% 25.74% 61.31% 112.20% (166.66%)
ROA
(655.94%) (484.99%) (946.99%) (457.48%) (234.29%) (130.91%) (53.48%) (122.05%) (125.95%) 35.02%
ROIC
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 26.60%
Return on Tangible Assets
92.98% 55.97% 75.89% 106.24% 111.38% 53.61% 19.52% 47.76% 123.80% 134.97%
Average Days of Receivables
122.22 75.37 46.32 26.79 211.96 67.75 87.84 59.30 37.23 44.93
Earnings Yield
1.61% 1.61% 1.61% 1.61% 1.61% 1.61% 1.61% 1.61% (32.39%) 4.81%
Free Cash Flow Yield
0.85% 0.85% 0.85% 0.85% 0.85% 0.85% 0.85% 0.85% 1.91% 2.86%
Free Cash Flow per Share
(11.04) (4.08) (9.07) (11.76) (12.51) (4.96) (11.35) (2.13) 0.44 0.85
Book value per Share
(23.78) (26.36) (38.03) (18.31) (13.44) (27.84) (27.64) (20.40) (3.54) 0.19
Free Cash Flow
(3.21) (1.53) (3.66) (6.46) (12.77) (6.94) (16.84) (4.52) 1.97 7.31
EV/EBIT
16.16 16.16 16.16 16.16 16.16 16.16 16.16 16.16 30.61 53.70
Other line items

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026